Vital Therapies Inc (NASDAQ:VTL) has received a consensus recommendation of “Hold” from the seven research firms that are covering the company, MarketBeat Ratings reports. Seven investment analysts have rated the stock with a hold rating. The average 12 month price target among brokers that have issued a report on the stock in the last year is $6.00.